ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Former Roche Exec To Lead AstraZeneca

by Ann M. Thayer
September 3, 2012 | APPEARED IN VOLUME 90, ISSUE 36

Soriot
[+]Enlarge
Credit: AstraZeneca
09036-buscon-PascalSoriotcxd.jpg
Credit: AstraZeneca

Pascal Soriot, former head of Roche’s pharmaceutical division, has been named AstraZeneca’s new CEO. He will join AstraZeneca on Oct. 1, and interim CEO Simon Lowth will return to his role as chief financial officer. Prior to starting his now 26-year career in the drug industry, Soriot, 53, was a practicing veterinarian. Meanwhile, effective Sept. 1, Daniel O’Day will lead Roche Pharma and Roland Diggelmann will succeed him as head of Roche Diagnostics.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment